Cargando…

Free access to medicines for the treatment of chronic diseases in Brazil

OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavares, Noemia Urruth Leão, Luiza, Vera Lucia, Oliveira, Maria Auxiliadora, Costa, Karen Sarmento, Mengue, Sotero Serrate, Arrais, Paulo Sergio Dourado, Ramos, Luiz Roberto, Farias, Mareni Rocha, Pizzol, Tatiane da Silva Dal, Bertoldi, Andréa Dâmaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157908/
https://www.ncbi.nlm.nih.gov/pubmed/27982374
http://dx.doi.org/10.1590/S1518-8787.2016050006118
_version_ 1782481530843561984
author Tavares, Noemia Urruth Leão
Luiza, Vera Lucia
Oliveira, Maria Auxiliadora
Costa, Karen Sarmento
Mengue, Sotero Serrate
Arrais, Paulo Sergio Dourado
Ramos, Luiz Roberto
Farias, Mareni Rocha
Pizzol, Tatiane da Silva Dal
Bertoldi, Andréa Dâmaso
author_facet Tavares, Noemia Urruth Leão
Luiza, Vera Lucia
Oliveira, Maria Auxiliadora
Costa, Karen Sarmento
Mengue, Sotero Serrate
Arrais, Paulo Sergio Dourado
Ramos, Luiz Roberto
Farias, Mareni Rocha
Pizzol, Tatiane da Silva Dal
Bertoldi, Andréa Dâmaso
author_sort Tavares, Noemia Urruth Leão
collection PubMed
description OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95%CI) and applied the Pearson’s Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5%; 95%CI 45.1–50.0). The prevalences of free access were higher among men (51.4%; 95%CI 48.1–54.8), age group of 40-59 years (51.1%; 95%CI 48.1–54.2), and in the poorest social classes (53.9%; 95%CI 50.2–57.7). The majority of medicines that act on the cardiovascular system, such as diuretics (C03) (78.0%; 95%CI 75.2–80.5), beta-blockers (C07) (62.7%; 95%CI 59.4–65.8), and the agents that work in the renin-angiotensin system (C09) (73.4%; 95%CI 70.8–75.8), were obtained for free. Medicines that act on the respiratory system, such as agents against obstructive airway diseases (R03) (60.0%; 95%CI 52.7–66.9) were mostly paid with own resources. CONCLUSIONS: Free access to medicines for treatment of chronic diseases occurs to a considerable portion of the Brazilian population, especially for the poorest ones, indicating decreased socioeconomic inequalities, but with differences between regions and between some classes of medicines.
format Online
Article
Text
id pubmed-5157908
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-51579082016-12-20 Free access to medicines for the treatment of chronic diseases in Brazil Tavares, Noemia Urruth Leão Luiza, Vera Lucia Oliveira, Maria Auxiliadora Costa, Karen Sarmento Mengue, Sotero Serrate Arrais, Paulo Sergio Dourado Ramos, Luiz Roberto Farias, Mareni Rocha Pizzol, Tatiane da Silva Dal Bertoldi, Andréa Dâmaso Rev Saude Publica Original Articles OBJECTIVE: To analyze the free access to medicines for the treatment of chronic diseases in the Brazilian population, according to demographic and socioeconomic factors. We also analyzed the most used pharmacological groups, according to funding source: free-of-charge or out-of-pocket paid. METHODS: Analysis of data from the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM – National Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based household survey, of cross-sectional design, based on probabilistic sample of the Brazilian population. We analyzed as outcome the prevalence of free access (free-of-charge) to all medicines for treatment of the reported chronic diseases, in the last 30 days. We studied the following independent variables: sex, age group, education in complete years of school, economic class, health plan, and geographical region of residence. We estimated the prevalences and 95% confidence intervals (95%CI) and applied the Pearson’s Chi-squared test to assess the differences between the groups, considering a 5% significance level. RESULTS: About half of adults and older adults who have had full access to the treatment of chronic diseases in Brazil obtained all needed medicines for free (47.5%; 95%CI 45.1–50.0). The prevalences of free access were higher among men (51.4%; 95%CI 48.1–54.8), age group of 40-59 years (51.1%; 95%CI 48.1–54.2), and in the poorest social classes (53.9%; 95%CI 50.2–57.7). The majority of medicines that act on the cardiovascular system, such as diuretics (C03) (78.0%; 95%CI 75.2–80.5), beta-blockers (C07) (62.7%; 95%CI 59.4–65.8), and the agents that work in the renin-angiotensin system (C09) (73.4%; 95%CI 70.8–75.8), were obtained for free. Medicines that act on the respiratory system, such as agents against obstructive airway diseases (R03) (60.0%; 95%CI 52.7–66.9) were mostly paid with own resources. CONCLUSIONS: Free access to medicines for treatment of chronic diseases occurs to a considerable portion of the Brazilian population, especially for the poorest ones, indicating decreased socioeconomic inequalities, but with differences between regions and between some classes of medicines. Faculdade de Saúde Pública da Universidade de São Paulo 2016-12-01 /pmc/articles/PMC5157908/ /pubmed/27982374 http://dx.doi.org/10.1590/S1518-8787.2016050006118 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Tavares, Noemia Urruth Leão
Luiza, Vera Lucia
Oliveira, Maria Auxiliadora
Costa, Karen Sarmento
Mengue, Sotero Serrate
Arrais, Paulo Sergio Dourado
Ramos, Luiz Roberto
Farias, Mareni Rocha
Pizzol, Tatiane da Silva Dal
Bertoldi, Andréa Dâmaso
Free access to medicines for the treatment of chronic diseases in Brazil
title Free access to medicines for the treatment of chronic diseases in Brazil
title_full Free access to medicines for the treatment of chronic diseases in Brazil
title_fullStr Free access to medicines for the treatment of chronic diseases in Brazil
title_full_unstemmed Free access to medicines for the treatment of chronic diseases in Brazil
title_short Free access to medicines for the treatment of chronic diseases in Brazil
title_sort free access to medicines for the treatment of chronic diseases in brazil
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157908/
https://www.ncbi.nlm.nih.gov/pubmed/27982374
http://dx.doi.org/10.1590/S1518-8787.2016050006118
work_keys_str_mv AT tavaresnoemiaurruthleao freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT luizaveralucia freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT oliveiramariaauxiliadora freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT costakarensarmento freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT menguesoteroserrate freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT arraispaulosergiodourado freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT ramosluizroberto freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT fariasmarenirocha freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT pizzoltatianedasilvadal freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil
AT bertoldiandreadamaso freeaccesstomedicinesforthetreatmentofchronicdiseasesinbrazil